<DOC>
	<DOCNO>NCT02692378</DOCNO>
	<brief_summary>The purpose study investigate whether oral sodium bicarbonate supplementation ensure constant bicarbonate profile haemodialysis patient primarily low predialysis potassium level secondary lead improvement cardiac function , muscle mass dialysis relate symptom .</brief_summary>
	<brief_title>Effects Oral Sodium Bicarbonate Supplementation Haemodialysis Patients ( BicHD )</brief_title>
	<detailed_description>Background : One function dialysis correct electrolyte abnormality occur renal failure , variation potassium bicarbonate level , link important clinical outcome patient . Metabolic acidosis , reflect fall bicarbonate level , frequent event haemodialysis patient correction one goal effective dialysis . Bicarbonate replacement routinely deliver dialysis session thrice weekly use high dialysate bicarbonate . However , local national data show 50 % patient fail meet bicarbonate level within normal range dialysis session . Low predialysis bicarbonate level less 22mmols/L link increase all-cause mortality haemodialysis patient . Evidence previous study suggest continuous replacement ( i.e . daily ) oral sodium bicarbonate capsule may superior correction acidosis current treatment intermittent replacement dialysis . Aims objectives : This randomise control study aim investigate effect oral sodium bicarbonate supplementation : Primary objective : Pre post dialysis potassium without increase intradialytic potassium gradient . Secondary objective : 1 . Risk arrhythmia measure ECG analysis 2 . Muscle mass measure body composition monitor 3 . Muscle function measure handgrip strength 4 . Haemodialysis related cramp measure symptom scale-renal questionnaire Patients recruit Imperial College Healthcare NHS ( National Heath Service ) Trust haemodialysis unit randomise two equally numbered group . One group receive standard dialysis treatment ( control ) one receive standard dialysis addition capsule sodium bicarbonate ( intervention ) . The dose sodium bicarbonate adjust accord individual level . The study duration 16 week .</detailed_description>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>Patients haemodialysis least 3 month , Patients primarily predialysis bicarbonate level le 22mmols/L last 6 month , Patients already take oral sodium bicarbonate , Able willing provide write informed consent Patients primarily predialysis potassium level less 4mmols/L last 6 month , Patients already take oral sodium bicarbonate , Patients lithium , Bedbound patient , Pregnant patient , Dementia , Recurrent hospital admission , NonEnglish speaking unable provide write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Haemodialysis</keyword>
	<keyword>sodium bicarbonate</keyword>
	<keyword>potassium</keyword>
	<keyword>arrhythmia</keyword>
	<keyword>muscle</keyword>
	<keyword>symptom</keyword>
</DOC>